National Biopharma Mission (Download PDF)

()

Download PDF of This Page (Size: 229.15 K)

It is an Industry-Academia Collaborative for Accelerating Discovery Research to Early Development for Biopharmaceuticals. Program under Innovate in India (i3) with investment of USD 250 million with USD 125 million loan from World Bank to create an enabling ecosystem promoting entrepreneurship and indigenous manufacturing.

  • Indian biopharmaceutical industry 10 - 15 years behind their counterparts in the developed countries.
  • India has only 2.8 % share in the global biopharmaceutical market. Elevate this to 5%
  • Faces stiff competition from China, Korea and others
  • Accelerate the translation of research into viable products
  • Implemented by Biotechnology Industry Research Assistance Council (BIRAC- Public Sector Undertaking of Department of Biotechnology)

Aim of Mission

Enable and nurture an ecosystem for preparing India’s technological and product development capabilities in biopharmaceuticals to a level that will be globally competitive over the next decade, and transform the health standards of India’s population through affordable product development

Image of Indian Pharmaceutical Industry

Image of Indian Pharmaceutical Industry

Image of Indian Pharmaceutical Industry

The Indian pharmaceuticals market increased at a CAGR of 17.46 per cent during 2005 - 16 with the market increasing from US $6 billion in 2005 to US $36.7 billion in 2016.

  • Expected to expand at a CAGR of 15.92 per cent to US $55 billion by 2020.
  • India to be among the top three pharmaceutical markets.
  • Cost of production significantly lower than that of the US
{"chart":{"plotBackgroundColor":null,"plotShadow":true,"backgroundColor":"transparent","width":600},"title":{"text":"Revenue of Indian Pharmaceutical Sector(US$ Billion)"},"tooltip":{"pointFormat":"{series.name}: {point.y}"},"credits":{"enabled":false},"xAxis":{"categories":["2005","2013","2015","2016","2020F"],"title":{"text":"Year"}},"yAxis":{"type":"linear","title":{"text":"US$ Billion"}},"plotOptions":{"series":{"allowPointSelect":true,"cursor":"pointer"}},"legend":{"floating":false,"backgroundColor":"white","borderColor":"silver","borderWidth":1,"shadow":true,"align":"right"},"series":[{"type":"column","name":"Revenue of Indian Pharmaceutical Sector (US$ Billion)","data":[6,12,30,36.7,55],"colors":[{"linearGradient":{"x1":0,"y1":0,"x2":0,"y2":1},"stops":[[0,"#f7a35c"],[1,"rgb(171,87,16)"]]},{"linearGradient":{"x1":0,"y1":0,"x2":0,"y2":1},"stops":[[0,"#8085e9"],[1,"rgb(52,57,157)"]]},{"linearGradient":{"x1":0,"y1":0,"x2":0,"y2":1},"stops":[[0,"#f15c80"],[1,"rgb(165,16,52)"]]},{"linearGradient":{"x1":0,"y1":0,"x2":0,"y2":1},"stops":[[0,"#e4d354"],[1,"rgb(152,135,8)"]]},{"linearGradient":{"x1":0,"y1":0,"x2":0,"y2":1},"stops":[[0,"#2b908f"],[1,"rgb(0,68,67)"]]},{"linearGradient":{"x1":0,"y1":0,"x2":0,"y2":1},"stops":[[0,"#f45b5b"],[1,"rgb(168,15,15)"]]},{"linearGradient":{"x1":0,"y1":0,"x2":0,"y2":1},"stops":[[0,"#91e8e1"],[1,"rgb(69,156,149)"]]},{"linearGradient":{"x1":0,"y1":0,"x2":0,"y2":1},"stops":[[0,"#7cb5ec"],[1,"rgb(48,105,160)"]]},{"linearGradient":{"x1":0,"y1":0,"x2":0,"y2":1},"stops":[[0,"#434348"],[1,"rgb(0,0,0)"]]},{"linearGradient":{"x1":0,"y1":0,"x2":0,"y2":1},"stops":[[0,"#90ed7d"],[1,"rgb(68,161,49)"]]}],"dataLabels":{"enabled":true,"style":{"color":"black"},"connectorColor":"silver"}}]}
Created with Highcharts 5.0. 12YearUS$ BillionRevenue of Indian Pharmaceutical Sector (US$ Billion) 661212303036.736.75555Revenue of Indian Pharmaceutical Sector (US$ Billion) 20052013201520162020F02040602015Revenue of Indian Pharmaceutical Sector (US$ Billion): 30
{"chart":{"plotBackgroundColor":null,"plotShadow":true,"backgroundColor":"transparent","width":600},"title":{"text":"Revenue share of Indian Pharmaceutical Sub-Segments in 2015(%)"},"tooltip":{"pointFormat":"{series.name}: {point.y}"},"credits":{"enabled":false},"xAxis":{},"yAxis":{},"plotOptions":{"series":{"allowPointSelect":true,"cursor":"pointer"}},"legend":{"floating":false,"backgroundColor":"white","borderColor":"silver","borderWidth":1,"shadow":true,"align":"right"},"series":[{"type":"pie","name":"Indian Pharmaceutical Sub-Segments in 2015(%)","data":[["Generic Drugs(70%)",70],["OTC Medicines(21%)",21],["Patented Drugs(9%)",9]],"colors":[{"radialGradient":{"cx":0.5,"cy":0.3,"r":0.7},"stops":[[0,"#434348"],[1,"rgb(0,0,0)"]]},{"radialGradient":{"cx":0.5,"cy":0.3,"r":0.7},"stops":[[0,"#90ed7d"],[1,"rgb(68,161,49)"]]},{"radialGradient":{"cx":0.5,"cy":0.3,"r":0.7},"stops":[[0,"#f7a35c"],[1,"rgb(171,87,16)"]]},{"radialGradient":{"cx":0.5,"cy":0.3,"r":0.7},"stops":[[0,"#8085e9"],[1,"rgb(52,57,157)"]]},{"radialGradient":{"cx":0.5,"cy":0.3,"r":0.7},"stops":[[0,"#f15c80"],[1,"rgb(165,16,52)"]]},{"radialGradient":{"cx":0.5,"cy":0.3,"r":0.7},"stops":[[0,"#e4d354"],[1,"rgb(152,135,8)"]]},{"radialGradient":{"cx":0.5,"cy":0.3,"r":0.7},"stops":[[0,"#2b908f"],[1,"rgb(0,68,67)"]]},{"radialGradient":{"cx":0.5,"cy":0.3,"r":0.7},"stops":[[0,"#f45b5b"],[1,"rgb(168,15,15)"]]},{"radialGradient":{"cx":0.5,"cy":0.3,"r":0.7},"stops":[[0,"#91e8e1"],[1,"rgb(69,156,149)"]]},{"radialGradient":{"cx":0.5,"cy":0.3,"r":0.7},"stops":[[0,"#7cb5ec"],[1,"rgb(48,105,160)"]]}],"dataLabels":{"enabled":true,"style":{"color":"black"},"connectorColor":"silver"}}]}
Created with Highcharts 5.0. 12Revenue share of Indian Pharmaceutical Sub-Segments in2015 (%) Revenue share of Indian Pharmaceutical Sub-Segments in 2015 (%) Generic Drugs (70%) Generic Drugs (70%) OTC Medicines (21%) OTC Medicines (21%) Patented Drugs (9%) Patented Drugs (9%) OTC Medicines (21%) Indian Pharmaceutical Sub-Segments in 2015 (%): 21

- Published/Last Modified on: July 7, 2017

Health

Monthy-updated, fully-solved, large current affairs-2019 question bank(more than 2000 problems): Quickly cover most-important current-affairs questions with pointwise explanations especially designed for IAS, NTA-NET, Bank-PO and other competetive exams.